Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / Ordinary Shares, par value $0.000006 per share
-
Shares outstanding
-
1.09B
-
Number of holders
-
80
-
Total 13F shares, excl. options
-
35.1M
-
Shares change
-
+14.1M
-
Total reported value, excl. options
-
$1.22B
-
Value change
-
+$493M
-
Number of buys
-
54
-
Number of sells
-
-26
-
Price
-
$34.87
Significant Holders of Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share (ZLAB) as of Q2 2019
94 filings reported holding ZLAB - Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share as of Q2 2019.
Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share (ZLAB) has 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35.1M shares
of 1.09B outstanding shares and own 3.21% of the company stock.
Largest 10 shareholders include FMR LLC (6.74M shares), WELLINGTON MANAGEMENT GROUP LLP (3.29M shares), Segantii Capital Management Ltd (3.29M shares), SC CHINA HOLDING Ltd (2.91M shares), BAMCO INC /NY/ (2.2M shares), BAILLIE GIFFORD & CO (2.09M shares), FEDERATED INVESTORS INC /PA/ (1.39M shares), CREDIT SUISSE AG/ (1.2M shares), ORBIMED ADVISORS LLC (1.17M shares), and GILDER GAGNON HOWE & CO LLC (1.16M shares).
This table shows the top 80 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.